Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Desogestrel
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Desogestrel 75microgram tablets
0703021Q0AAAAAA
|
Desogestrel | Desogestrel | Obstetrics, Gynaecology and Urinary-Tract Disorders | 394,249 |
|
Cerelle 75microgram tablets
0703021Q0BDAAAA
|
Cerelle | Desogestrel | Obstetrics, Gynaecology and Urinary-Tract Disorders | 75,314 |
|
Cerazette 75microgram tablets
0703021Q0BBAAAA
|
Cerazette | Desogestrel | Obstetrics, Gynaecology and Urinary-Tract Disorders | 38,868 |
|
Zelleta 75microgram tablets
0703021Q0BHAAAA
|
Zelleta | Desogestrel | Obstetrics, Gynaecology and Urinary-Tract Disorders | 15,988 |
|
Desorex 75microgram tablets
0703021Q0BFAAAA
|
Desorex | Desogestrel | Obstetrics, Gynaecology and Urinary-Tract Disorders | 2,632 |
|
Feanolla 75microgram tablets
0703021Q0BIAAAA
|
Feanolla | Desogestrel | Obstetrics, Gynaecology and Urinary-Tract Disorders | 455 |
|
Desomono 75microgram tablets
0703021Q0BGAAAA
|
Desomono | Desogestrel | Obstetrics, Gynaecology and Urinary-Tract Disorders | 353 |
|
Lovima 75microgram tablets
0703021Q0BKAAAA
|
Lovima | Desogestrel | Obstetrics, Gynaecology and Urinary-Tract Disorders | 181 |
|
Nacrez 75microgram tablets
0703021Q0BCAAAA
|
Nacrez | Desogestrel | Obstetrics, Gynaecology and Urinary-Tract Disorders | 1 |
|
Aizea 75microgram tablets
0703021Q0BEAAAA
|
Aizea | Desogestrel | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Moonia 75microgram tablets
0703021Q0BJAAAA
|
Moonia | Desogestrel | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.